BioNano Genomics, Inc. (BNGO) Reports Q1 Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to BioNano Genomics, Inc. (BNGO) Reports Q1 Revenues Miss

Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update

June 18, 2020 4:01 PM EDT

SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today reported its financial results for the first quarter ended March 31, 2020 and provided a business update.

Recent Business Highlights

From January 1, 2020 through June 18, 2020, processed 416 customer samples compared to a total of 212 customer samples in 2019.Since commercial launch of Saphyr through March 31, 2020, shipped 116 Saphyr instruments, of which 83 have been installed.... More